Evidence map›Paper›PMID 40827735›Full record

ArticlePediatric pulmonology2025

Pulmonary Arterial Hypertension Requiring Medication Is Associated With Higher Prevalence of Thrombocytopenia in Pediatric Patients.

Tanya Reyna, Catherine Agarwal, Abrar Mamun, Jessica Dae, Yusuf Ozcan, Michael J Angtuaco, Taha Bat, Erhan Ararat

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric pulmonology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tanya ReynaDepartment of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Catherine AgarwalDepartment of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Abrar MamunDepartment of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID https://orcid.org/0009-0005-7220-6897
Jessica DaeDepartment of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Yusuf OzcanBiological Sciences, University of Texas at Dallas, Dallas, Texas, USA.
Michael J AngtuacoDepartment of Pediatrics, University of Arkansas for Medical Sciences, Dallas, Texas, USA.ORCID https://orcid.org/0000-0003-4057-3690
Taha BatDepartment of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Erhan AraratDepartment of Pediatrics, University of Arkansas for Medical Sciences, Dallas, Texas, USA.ORCID https://orcid.org/0000-0003-1880-4827

Funding

The authors received no specific funding for this work.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bone marrowhemoglobinleukocyteslungsplatelets

Identifiers

PMID40827735
PMCPMC12363154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.